These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8757692)

  • 21. First cases of Acanthamoeba keratitis in Slovakia.
    Ondriska F; Mrva M; Lichvár M; Ziak P; Murgasová Z; Nohýnková E
    Ann Agric Environ Med; 2004; 11(2):335-41. PubMed ID: 15627346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Free-living amoebae: pathogenicity and immunity.
    Ferrante A
    Parasite Immunol; 1991 Jan; 13(1):31-47. PubMed ID: 2014136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acanthamoeba keratitis: a review.
    Claerhout I; Kestelyn P
    Bull Soc Belge Ophtalmol; 1999; 274():71-82. PubMed ID: 10670164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Free-living amebas: infection of the central nervous system.
    Martinez AJ
    Mt Sinai J Med; 1993 Sep; 60(4):271-8. PubMed ID: 8232369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cure of Acanthamoeba cerebral abscess in a liver transplant patient.
    Fung KT; Dhillon AP; McLaughlin JE; Lucas SB; Davidson B; Rolles K; Patch D; Burroughs AK
    Liver Transpl; 2008 Mar; 14(3):308-12. PubMed ID: 18306348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental infection of T4 Acanthamoeba genotype determines the pathogenic potential.
    Alves Dde S; Moraes AS; Alves LM; Gurgel-Gonçalves R; Lino Junior Rde S; Cuba-Cuba CA; Vinaud MC
    Parasitol Res; 2016 Sep; 115(9):3435-40. PubMed ID: 27164833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri.
    Schuster FL; Guglielmo BJ; Visvesvara GS
    J Eukaryot Microbiol; 2006; 53(2):121-6. PubMed ID: 16579814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of pathogenic potential of Acanthamoeba isolates by in vitro and in vivo tests.
    Sharma C; Khurana S; Megha K; Thakur A; Bhatia A; Gupta A
    Parasitol Res; 2023 Sep; 122(9):2109-2118. PubMed ID: 37418019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the innate and adaptive immune responses in Acanthamoeba keratitis.
    Niederkorn JY
    Arch Immunol Ther Exp (Warsz); 2002; 50(1):53-9. PubMed ID: 11916309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of antibodies against free-living amoebae Balamuthia mandrillaris and Acanthamoeba species in a population of patients with encephalitis.
    Schuster FL; Honarmand S; Visvesvara GS; Glaser CA
    Clin Infect Dis; 2006 May; 42(9):1260-5. PubMed ID: 16586385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in the treatment of Acanthamoeba keratitis.
    Kumar R; Lloyd D
    Clin Infect Dis; 2002 Aug; 35(4):434-41. PubMed ID: 12145728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ante mortem diagnosis of amoebic encephalitis in a haematopoietic stem cell transplanted patient.
    Abd H; Saeed A; Jalal S; Bekassy AN; Sandström G
    Scand J Infect Dis; 2009; 41(8):619-22. PubMed ID: 19479635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatal granulomatous amoebic encephalitis caused by Acanthamoeba in a newly diagnosed patient with systemic lupus erythematosus.
    Thamtam VK; Uppin MS; Pyal A; Kaul S; Rani JY; Sundaram C
    Neurol India; 2016; 64(1):101-4. PubMed ID: 26755000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and management of Acanthamoeba keratitis.
    Hammersmith KM
    Curr Opin Ophthalmol; 2006 Aug; 17(4):327-31. PubMed ID: 16900022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case report of granulomatous amoebic encephalitis by Group 1 Acanthamoeba genotype T18 diagnosed by the combination of morphological examination and genetic analysis.
    Matsui T; Maeda T; Kusakabe S; Arita H; Yagita K; Morii E; Kanakura Y
    Diagn Pathol; 2018 May; 13(1):27. PubMed ID: 29747695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenesis of Acanthamoeba infections.
    Khan NA
    Microb Pathog; 2003 Jun; 34(6):277-85. PubMed ID: 12782480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acanthamoeba spp. as opportunistic pathogens parasites].
    Castrillón JC; Orozco LP
    Rev Chilena Infectol; 2013 Apr; 30(2):147-55. PubMed ID: 23677153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous acanthamebiasis infection in immunocompetent and immunocompromised patients.
    Galarza C; Ramos W; Gutierrez EL; Ronceros G; Teran M; Uribe M; Navincopa M; Ortega-Loayza AG
    Int J Dermatol; 2009 Dec; 48(12):1324-9. PubMed ID: 20415673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial effect of auranofin against Acanthamoeba spp.
    Loufouma Mbouaka A; Leitsch D; Koehsler M; Walochnik J
    Int J Antimicrob Agents; 2021 Nov; 58(5):106425. PubMed ID: 34419578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Report of a case of Acanthamoeba keratitis].
    Carrette S; Marechal-Courtois C; Hernandez J; Hayette MP; Deprez M; Duchesne B
    Bull Soc Belge Ophtalmol; 2000; 275():49-53. PubMed ID: 10853307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.